Cargando…
FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition
PURPOSE: Fibroblast growth factor receptor 4 (FGFR4) plays a critical role in cancer progression involving in tumor proliferation, invasion, and metastasis. This study clarified the role of FGFR4-Arg388 variant in gastric cancer (GC), and more importantly highlighted the possibility of this single n...
Autores principales: | Ye, Yanwei, Li, Jie, Jiang, Dongbao, Li, Jingjing, Xiao, Chuangfeng, Li, Yingze, Han, Chao, Zhao, Chunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577822/ https://www.ncbi.nlm.nih.gov/pubmed/32599983 http://dx.doi.org/10.4143/crt.2020.138 |
Ejemplares similares
-
FGFR4 GLY388ARG polymorphism modulates cancer patients' survival in pooled analysis
por: Frullanti, Elisa, et al.
Publicado: (2010) -
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis
por: Matakidou, A, et al.
Publicado: (2007) -
Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility
por: Chou, Chia-Hsuan, et al.
Publicado: (2017) -
Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis
por: Xiong, Si-Wei, et al.
Publicado: (2017) -
FGFR4 Arg388 Is Correlated with Poor Survival in Resected Colon Cancer Promoting Epithelial to Mesenchymal Transition
por: Cho, Sang Hee, et al.
Publicado: (2017)